CG
FUSN

Cutler Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Cutler Group’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1K Buy
1,400
+500
+56% +$5.98K ﹤0.01% 2163
2023
Q4 		$1K Buy
+900
New +$4.37K ﹤0.01% 3523

Other funds holding FUSN

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cutler Group's FUSN Position: Q1 2024 in Review

Cutler Group increased its Fusion Pharmaceuticals Inc. Common Shares (FUSN) stake by 682% in Q1 2024, buying an estimated $89.7K and bringing the position to 8,600 shares worth $183K. The position accounts for 0.06% of the portfolio, ranked #304.

Cutler Group first reported a position in FUSN in Q3 2021 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

  • Cutler Group held 8,600 shares of Fusion Pharmaceuticals Inc. Common Shares worth $183K as of Q1 2024.
  • Cutler Group bought 7,500 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $89.7K.
  • Fusion Pharmaceuticals Inc. Common Shares made up 0.06% of Cutler Group's portfolio in Q1 2024, its #304 holding.
  • Cutler Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2021 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.